-
The Quest for a Malaria Vaccine Continues
The 2016 World Malaria Report estimates that there were approximately 215 million cases of malaria and 438,000 deaths in 2015. The majority of deaths occur in sub-Saharan Africa and among young children, and malaria remains endemic in around 100 countries with over three billion people at risk. Over the past 15 years there have been major gains in reducing the global burden of malaria; however, it continues to be a major cause of mortality and morbidity globally. The 25th of April marks World Malaria Day, highlighting key issues in the fight against this major disease. Plasmodium falciparum causes the bulk of malaria, with P. vivax being a second major cause. World Malaria Day 2016 highlights the need for innovation to develop effective vaccines, new drugs, and better diagnostics to ensure continued success towards malaria elimination.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
#WorldMalariaDay: Report – Six African Nations Could be Malaria-free by 2020
Within the next four years, six nations in Africa – the region where malaria is most prominent – could be free of the disease, the World Health Organization said in a report published Monday to mark World Malaria Day.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
#WorldMalariaDay Opinion: We can beat malaria if we move faster
Vector control has been an important weapon in the fight against malaria. Indoor residual sprays and treated bed nets are now in use widely across Africa and Asia to kill mosquitoes and protect people. However, the Anopheles mosquito, the vector that transmits malaria to humans, is becoming increasingly resistant to pyrethroids, one of the most commonly used insecticides.
- Categories
- Health Care
-
A Toilet for India That Also Delivers Clean Water
In India, 600 million people lack access to a clean toilet, and, lately, the government has been on a big drive to build more of them. Prime Minister Narendra Modi’s "Clean India" campaign aims to provide decent sanitation to all Indians by 2019.
- Categories
- Health Care
- Region
- South Asia
-
Nigeria: Vaccine Bill to Hit U.S. $345 Million as Donor Support Vanishes
The National Primary Health Care Development Agency (NPHCDA) says government spending on immunisation is expected to top $345 million a year by 2022 when international funding support from the Global Alliance for Vaccine Initiative (GAVI) is completely withdrawn.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
No Radiotherapy, No MRI, No Money: Uganda’s Health Funding Crisis
Monday 11 April was not a normal day in the radiotherapy clinic at the Mulago National Referral hospital in Kampala.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
J&J Ebola Vaccine Has Promise as Wider Test Awaits Next Outbreak
An experimental Ebola vaccine from Johnson & Johnson, boosted by a second immunization shot from biotechnology company Bavarian Nordic A/S, generated a powerful immune response among volunteers in its first tests in humans.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
‘India Makes All Mylan HIV Drugs for Developing World’
Rajiv Malik is president of Mylan, the $9.5-billion, Nasdaq-listed global generic and speciality pharmaceuticals company. Malik became part of Mylan in 2007 when the latter acquired India-based Matrix Laboratories, where he was CEO. That deal also transformed Mylan, which till then operated only in the US, into one of the world's largest manufacturers of active pharmaceutical ingredients (APIs). On a recent visit to Bengaluru, Malik spoke to TOI:
- Categories
- Health Care
- Region
- South Asia
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.